+ More Filters

Reset Filters

Title

Funding Organization

Funding Type

Eligible Country

Deadline

Other (Select all that apply)

Show Expired Programs

Show Verified Programs

Not Verified

EHA Research Mobility Grant

European Hematology Association

EHA Research Mobility Grants are designed to support the professional development of young scientists by enabling mobility and facilitating a visit to a research group in another institute.

Both institutes should have complementary expertise, as this visit is intended to promote collaboration between the institutes.

The grants:

Support basic and translational early-career researchers in hematology
Last for up to three months
Can provide a total award of up to €7,500 within Europe and €10,000 outside of Europe

EHA Research Mobility Grant covers

An EHA Research Mobility Grant covers:

A visit of up to three months
Travel and accommodation expenses up to €7,500 for travel within Europe and up to €10,000 outside Europe
A small contribution towards lab consumables—which must be approved by the EHA Grants Manager before you submit your application

If the project is for a longer duration (up to six months), you must provide an explanation.

An EHA Research Mobility Grant does not cover:

Overhead costs
Your salary
Travel support for other people
Funding for existing projects
Purchase of equipment or other items supporting your stay at the host institute (such as furniture, car, computer, etc.)

If this grant does not fully cover your expenses, you must share details of how you’ll cover them. 

All expenditures must be documented with original receipts, vouchers, or invoices.

AI Based Application Success Predictor

🩸 1. Strong Focus on Hematology (Non-Negotiable)

Projects must directly address:
- Blood disorders
Includes:
- Leukemia, lymphoma, myeloma
- Anemia, coagulation disorders
- Bone marrow failure syndromes

👉 Weak hematology relevance → low success probability

🎯 2. Clear Clinical or Translational Impact (Top Predictor)

Successful proposals:

Demonstrate:
- Direct relevance to patient care or disease outcomes
Aim to:
- Improve diagnosis, therapy, or prognosis

👉 Key question:
“Will this improve outcomes for patients with hematologic diseases?”

🔄 3. Translational Research Emphasis (Critical)

Strong preference for:
- Bench → bedside research
Includes:
- Biomarkers
- Targeted therapies
- Clinical trials

👉 Pure basic science is less competitive unless clinically linked

👩‍🔬 4. Early-Career Investigator Development (Major Priority)

Many EHA programs target:
- Young investigators and trainees

Evaluation includes:

Career trajectory
Independence potential

👉 Strong advantage for early-career applicants

🧪 5. Feasible, Well-Structured Research Plan

Must include:
- Clear aims
- Methodology
- Timeline

👉 Realistic scope is critical (often 1–3 year funding)

🤝 6. High-Quality Host Institution (For Fellowships)

Host center must:
- Provide advanced hematology expertise
Often requires:
- International mobility

👉 Strong host justification improves success

🌍 7. European Collaboration & Mobility

Preference for:
- Cross-country training/research
Encourages:
- Knowledge exchange within Europe

👉 Mobility is a core evaluation factor

🧬 8. Innovation in Hematology

High success in:

Precision medicine
Immunotherapy (CAR-T, etc.)
Genomics and molecular diagnostics

👉 Innovation must be clinically meaningful

📊 9. Alignment with EHA Priority Areas

Higher success rates in:

Hematologic malignancies
Rare blood disorders
Personalized medicine
Translational hematology

👉 Aligning with EHA themes improves competitiveness

💰 10. Clear Training & Career Benefit

For fellowships:

Applicants must show:
- Skills they will gain
- Career advancement

👉 Training value is often as important as research quality

📊 Summary: Key Predictors (Ranked)

Highest impact factors:

Hematology focus
Clinical/translational impact
Research quality

Moderate predictors:
4. Early-career development
5. Feasibility
6. Host institution quality

Supporting factors:
7. Collaboration/mobility
8. Innovation
9. Training benefit

Specialties

Hematology

Eligibility Requirements

You’re eligible if:

You’re an EHA member
The home and host institutes are academic research centers or proven equivalents
The home and host institutes are in different countries and at least one of them is in Europe
You have the support of an academic department and institute
Your application relates to basic and translational lab-based research in hematology, as purely clinical research projects, projects in health economics, and other non-lab-based research are ineligible

In addition, at least one of the following statements must apply:

You are a PhD student
You are within one year of PhD graduation
You are an MD in training (with residency and within one year of hematology accreditation), with a keen interest in pursuing a career in research

Sponsor Details

Sponsor Institute/Organizations: European Hematology Association

Sponsor Type: Corporate/Non-Profit

Address: Koninginnegracht 12b 2514 AA The Hague

Legal & Affiliation Disclaimer

Affiliation Disclaimer: Trialect operates independently and is not affiliated with, endorsed by, or supported by any sponsors or organizations posting on the GrantsBoard platform. As an independent aggregator of publicly available funding opportunities, Trialect provides equal access to information for all users without endorsing any specific funding source, content, organization, or sponsor. Trialect assumes no responsibility for the content posted by sponsors or third parties.

Subscription Disclaimer: Upon logging into Trialect, you may choose to SUBSCRIBE to GrantsBoard for timely notifications of funding opportunities and to access exclusive benefits, such as priority alerts, reminders, personalized recommendations, and additional application support. However, users are advised to contact sponsors directly for any questions and are not required to subscribe to engage with funding opportunities.

Content Ownership and Copyright Disclaimer: Trialect respects the intellectual property rights of all organizations and individuals. All content posted on GrantsBoard is provided solely for informational purposes and remains the property of the original owners. Trialect does not claim ownership of, nor does it have any proprietary interest in, content provided by third-party sponsors. Users are encouraged to verify content and ownership directly with the posting sponsor.

Fair Use Disclaimer: The information and content available on GrantsBoard are compiled from publicly accessible sources in alignment with fair use principles under U.S. copyright law. Trialect serves as an aggregator of this content, offering it to users in good faith and with the understanding that it is available for public dissemination. Any organization or individual who believes their intellectual property rights have been violated is encouraged to contact us for prompt resolution.

Third-Party Posting Responsibility Disclaimer: Trialect is a neutral platform that allows third-party sponsors to post funding opportunities for informational purposes only. Sponsors are solely responsible for ensuring that their postings comply with copyright, trademark, and other intellectual property laws. Trialect assumes no liability for any copyright or intellectual property infringements in third-party content and will take appropriate action to address any substantiated claims.

Accuracy and Verification Disclaimer: Trialect makes no warranties regarding the accuracy, completeness, or reliability of the information provided by sponsors. Users are advised to verify the details of any funding opportunity directly with the sponsor before taking action. Trialect cannot be held liable for any discrepancies, omissions, or inaccuracies in third-party postings.

Notice and Takedown Policy: Trialect is committed to upholding copyright law and protecting the rights of intellectual property owners. If you believe that content on GrantsBoard infringes your copyright or intellectual property rights, please contact us with detailed information about the claim. Upon receipt of a valid notice, Trialect will promptly investigate and, where appropriate, remove or disable access to the infringing content.

View Funding Opportunity